Created at	Source	Raw Value	Validated value
Feb. 1, 2023, 4 p.m.	usa	Cumulative Incidence of Severe Infusion Reactions;Cumulative Incidence of Treatment-related Acute Respiratory Distress Syndrome (ARDS);Cumulative Incidence of Treatment-related Grade 3 or Higher Adverse Events;Cumulative Number of Hospitalizations or Deaths Prior to Hospitalization	Cumulative Incidence of Severe Infusion Reactions;Cumulative Incidence of Treatment-related Acute Respiratory Distress Syndrome (ARDS);Cumulative Incidence of Treatment-related Grade 3 or Higher Adverse Events;Cumulative Number of Hospitalizations or Deaths Prior to Hospitalization
Oct. 26, 2020, 11:31 p.m.	usa	Cumulative incidence of hospitalization or death prior to hospitalization;Cumulative incidence of treatment-related grade 3 or higher adverse events;Cumulative incidence of treatment-related serious adverse events	Cumulative incidence of hospitalization or death prior to hospitalization;Cumulative incidence of treatment-related grade 3 or higher adverse events;Cumulative incidence of treatment-related serious adverse events